Royal Marsden NHS Foundation Trust

Futó vizsgálatok

• Toboroz

  A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

  NCT07549321· 2/3. fázis· Forrás

• Toboroz

  Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

  NCT07096778· 2. fázis· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Forrás

• Toboroz

  Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

  NCT06190899· 1/2. fázis· Forrás

• Toboroz

  Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  NCT05413421· 1. fázis· Forrás

• Toboroz

  A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  NCT05131022· 1. fázis· Forrás

• Fut, nem toboroz

  Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

  NCT04675294· 2. fázis· Forrás

• Fut, nem toboroz

  Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

  NCT04579380· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

  NCT04607421· 3. fázis· Forrás

• Fut, nem toboroz

  GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

  NCT04083599· 1/2. fázis· Forrás

• Fut, nem toboroz

  First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

  NCT03625037· 1/2. fázis· Forrás

• Toboroz

  Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial

  NCT02704520· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Prosztatarák2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Follikuláris limfóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Mielóma multiplex1 toboroz
• Neuroblasztóma1 toboroz
• Tüdőrák1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck

  NCT04665843· 2. fázis· Forrás

• Lezárult

  Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

  NCT04295577· Forrás

• Leállították

  PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin

  NCT04021277· 1. fázis· Forrás

• Leállították

  Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

  NCT03869190· 1/2. fázis· Forrás

• Leállították

  A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

  NCT03452137· 3. fázis· Forrás

• Lezárult

  ATRi Transition Rollover Study

  NCT03309150· 1. fázis· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Forrás

• Lezárult

  Phase I Trial of VS-6766 Alone and in Combination With Everolimus

  NCT02407509· 1. fázis· Forrás